Who might it be?With the "extra" time on our hands I have been following the 3 biggest players in the stent business; Boston Scientific, Medtronics, and Johnson & Johnson. These three companies are currently battling each other for market share. In my opinion, Boston Scientific is out of the running with their current deal with Guidant. So in my mind that leaves Johnson & Johnson and Medtronics battling for our Revas. Just today Medtronics released news that stated that an "arbitration panel has found in favor of Medtronic, Inc in a case in which Johnson & Johnson/Cordis alleged that the Medtronic Driver™ stent and several other Medtronic stents infringed certain Cordis patents. The arbitration panel issued its non-appealable decision on February 20 and the award became final on March 22."
I find this interesting. Could this be the delay we have experienced and could news be on its way?
Any other thoughts out there?